Patents by Inventor Dave Haugaard

Dave Haugaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050096529
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: November 1, 2004
    Publication date: May 5, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20050085801
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: October 15, 2004
    Publication date: April 21, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20050049615
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: October 15, 2004
    Publication date: March 3, 2005
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel Cooper, Bryan Loomas, Don Tanaka, Michael Laufer, David Thompson, James Davenport, Gary Kaplan, Dave Haugaard, Glendon French
  • Publication number: 20040073201
    Abstract: The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 15, 2004
    Applicant: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Patent number: 6712812
    Abstract: The devices disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices produce collateral openings or channels through the airway wall so that oxygen depleted/carbon dioxide rich air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: March 30, 2004
    Assignee: Broncus Technologies, Inc.
    Inventors: Ed Roschak, Don Tanaka, Dave Haugaard, Thomas Keast
  • Patent number: 6692494
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: February 17, 2004
    Assignee: Broncus Technologies, Inc.
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, James M. Davenport, Gary Kaplan, Dave Haugaard, Glendon E. French
  • Publication number: 20030233099
    Abstract: This relates to methods and devices for treating reversible chronic obstructive pulmonary disease, and more particularly, relates to a device for exchanging energy with airway tissue such as that found in the airway of human lungs. The exchange of energy with this airway tissue in the airways reduces the ability of the air ways to constrict and/or reduces the resistance within the airway to the flow of air through the airway. This also relates to a method for decreasing responsiveness or decreasing resistance to airflow of airways involves the transfer of energy to or from the airway walls to prevent or reduce airway constriction and other symptoms of lung diseases. The treatment reduces the ability of the airway to contract during an acute narrowing of the airways, reduces mucus plugging of the airways, and/or increases the airway diameter.
    Type: Application
    Filed: April 14, 2003
    Publication date: December 18, 2003
    Applicant: Broncus Technologies, Inc.
    Inventors: Christopher James Danaek, Michael Biggs, Keith M. Burger, Bryan Loomas, Thomas Keast, Dave Haugaard
  • Patent number: 6599311
    Abstract: Methods and assemblies for reducing the volume of a lung. A plurality of anchors are anchored at different positions in the lung. A cord is attached to each of the anchors. The anchors are drawn towards one another via the cords to cause the lung to collapse, thus compressing the tissue in the lung and establishing a reduction in lung volume.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: July 29, 2003
    Assignee: Broncus Technologies, Inc.
    Inventors: Michael Biggs, Bryan Loomas, Steven Masterson, Keith M. Burger, Dave Haugaard, James M. Davenport, John Arthur Ross
  • Publication number: 20020138074
    Abstract: Disclosed herein are devices for altering gaseous flow within a lung to improve the expiration cycle of an individual, particularly individuals having Chronic Obstructive Pulmonary Disease (COPD). More particularly, devices are disclosed to produce collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs.
    Type: Application
    Filed: February 21, 2002
    Publication date: September 26, 2002
    Inventors: Thomas Keast, Christopher Lee Willink, Ed Roschak, Dave Haugaard, David Thompson
  • Publication number: 20020128647
    Abstract: Disclosed herein are devices for altering gaseous flow within a lung to improve the expiration cycle of an individual, particularly individuals having Chronic Obstructive Pulmonary Disease (COPD). More particularly, devices are disclosed to produce collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs.
    Type: Application
    Filed: February 21, 2002
    Publication date: September 12, 2002
    Inventors: Ed Roschak, Thomas Keast, Hewlett E. Melton, Christopher Lee Willink, Dave Haugaard, David Thompson
  • Publication number: 20020087153
    Abstract: The devices disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices produce collateral openings or channels through the airway wall so that oxygen depleted/carbon dioxide rich air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs.
    Type: Application
    Filed: September 4, 2001
    Publication date: July 4, 2002
    Applicant: Broncus Technologies, Inc.
    Inventors: Ed Roschak, Don Tanaka, Dave Haugaard, Thomas Keast
  • Publication number: 20020042564
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Application
    Filed: July 18, 2001
    Publication date: April 11, 2002
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, Michael D. Laufer, David Thompson, Gary Kaplan, Dave Haugaard, Glendon E. French, Ed Roschak
  • Publication number: 20020042565
    Abstract: The devices and methods disclosed herein are directed to altering gaseous flow within a lung to improve the expiration cycle of, for instance, an individual having Chronic Obstructive Pulmonary Disease. More particularly, these devices and methods produce and to maintain collateral openings or channels through the airway wall so that expired air is able to pass directly out of the lung tissue to facilitate both the exchange of oxygen ultimately into the blood and/or to decompress hyper-inflated lungs. The devices and methods also disclose locating and selecting a site for creation of a collateral opening.
    Type: Application
    Filed: July 18, 2001
    Publication date: April 11, 2002
    Inventors: Joel D. Cooper, Bryan Loomas, Don Tanaka, David Thompson, Gary Kaplan, Dave Haugaard, Thomas Keast, John Arthur Ross